Suppliers in Fort Dodge, IA
14 Medicare Suppliers found. Showing 1 - 14
 Cvs Pharmacy # 10282 Durable Medical Equipment & Medical Supplies Location: 2029 5th Ave South, Fort Dodge, Iowa 50501 Phone: (515) 955-6453 |
Iowa Cvs Pharmacy Llc Durable Medical Equipment & Medical Supplies Location: 2910 1st Ave S, Fort Dodge, Iowa 50501 Phone: (515) 573-7202 |
Lincare Inc Durable Medical Equipment & Medical Supplies Location: 516 1st Ave N, Fort Dodge, Iowa 50501 Phone: (515) 576-8027 |
Wal-mart Pharmacy10-0886 Durable Medical Equipment & Medical Supplies Location: 3036 1st Ave S, Fort Dodge, Iowa 50501 Phone: (515) 576-7405 |
Daniel Pharmacy Medicare Supplier Location: 1114 Central Ave, Fort Dodge, Iowa 50501 Phone: (515) 573-3431 |
Hy-vee Pharmacy #1192 Durable Medical Equipment & Medical Supplies Location: 115 S 29th St, Fort Dodge, Iowa 50501 Phone: (515) 576-5320 |
Walgreens #5361 Durable Medical Equipment & Medical Supplies Location: 2503 5th Ave S, Fort Dodge, Iowa 50501 Phone: (515) 576-7113 |
Unitypoint At Home Durable Medical Equipment & Medical Supplies Location: 802 Kenyon Rd, Fort Dodge, Iowa 50501 Phone: (515) 574-8540 |
Unitypoint At Home Durable Medical Equipment & Medical Supplies Location: 214 S 25th St, Fort Dodge, Iowa 50501 Phone: (515) 955-1654 |
Hanger Clinic Durable Medical Equipment & Medical Supplies Location: 804 Kenyon Rd, Fort Dodge, Iowa 50501 Phone: (515) 576-8255 |
Jeffrey S Foreman Od Eye Care Medicare Supplier Location: 1511 1st Ave S, Fort Dodge, Iowa 50501 Phone: (515) 955-7777 |
Active Health Clinics Medicare Supplier Location: 20 N 29th St, Fort Dodge, Iowa 50501 Phone: (515) 227-7491 |
Central Iowa Eyecare Medicare Supplier Location: 1202 2nd Ave N, Fort Dodge, Iowa 50501 Phone: (515) 576-1261 |
Medical Arts Eyecare Plc Medicare Supplier Location: 1428 2nd Ave N, Fort Dodge, Iowa 50501 Phone: (515) 573-1145 |
News Archive
Liquidia commences dosing in LIQ-001 Phase 1 trial for seasonal influenza
Liquidia Technologies, a privately held nanotechnology company developing particle-based vaccines and therapeutics, today announced the initiation of human dosing of its lead vaccine product candidate, LIQ-001, in a Phase 1 clinical trial. LIQ-001, the first in a pipeline of PRINT® vaccines, is being developed as a seasonal influenza vaccine for enhanced protection in the elderly and represents the company's migration from proof of concept to the clinical application of PRINT technology.
Obsessive compulsive disorder evident as early as age four
Researchers in the U.S. say children as young as four can develop full-blown obsessive compulsive disorder (OCD).
U.S. Patent Office's patent issuance provides extensive protection to BDSI's drug delivery technology platforms
BioDelivery Sciences International, Inc. today announced the issuance of United States Patent 7,579,019, which will provide additional patent exclusivity for both ONSOLIS and BDSI's BEMA drug delivery technology platform until at least 2019.
Positive preliminary results from Alnylam's ALN-TTR01 Phase I clinical trial for TTR-mediated amyloidosis
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today positive preliminary results from its Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).
SARS-CoV-2 virus may target red marrow and prevent the formation of new erythrocytes
Specialists from the Department of Fundamental Medicine of Far Eastern Federal University (FEFU) with Russian and Japanese colleagues have probed into mechanisms of COVID-19 inside-the-body distribution linked to erythrocytes damaging.
› Verified 1 days ago